Coya Therapeutics to Present at the Oppenheimer Rare & Orphan Disease Summit

b'Headquartered in Houston, TX, Coya Therapeutics\xe2\x84\xa2 is a clinical-stage biotechnology company developing first-in-class and best-in-class approaches utilizing adoptive regulatory T cells (Tregs) to target disease.